We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $15.5B
1-Year Est. Return 38.81%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
-$224M
Cap. Flow %
-1.44%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.55%
2 Technology 16.4%
3 Industrials 13.64%
4 Consumer Discretionary 9.45%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGNX icon
1976
Regenxbio
RGNX
$488M
– –
-115,444
Closed -$967K
RIGL icon
1977
Rigel Pharmaceuticals
RIGL
$900M
– –
-10,851
Closed -$293K
RIO icon
1978
Rio Tinto
RIO
$154B
– –
-12,588
Closed -$1.17M
RIOT icon
1979
Riot Platforms
RIOT
$8.63B
– –
-369,635
Closed -$4.57M
RITM icon
1980
Rithm Capital
RITM
$5.1B
– –
-476,668
Closed -$4.52M
RIVN icon
1981
Rivian
RIVN
$22.4B
– –
-247,796
Closed -$3.73M
RNG icon
1982
RingCentral
RNG
$6.36B
– –
-109,084
Closed -$4.06M
RNR icon
1983
RenaissanceRe
RNR
$13.5B
– –
-13,350
Closed -$3.97M
RPRX icon
1984
Royalty Pharma
RPRX
$25.9B
– –
-123,562
Closed -$5.93M
RRC icon
1985
Range Resources
RRC
$9.02B
– –
-29,305
Closed -$1.32M
RRR icon
1986
Red Rock Resorts
RRR
$3B
– –
-27,218
Closed -$1.45M
RSP icon
1987
Invesco S&P 500 Equal Weight ETF
RSP
$96.8B
– –
-202,526
Closed -$38.9M
RTO icon
1988
Rentokil
RTO
$10.4B
– –
-8,049
Closed -$253K
RUN icon
1989
Sunrun
RUN
$1.95B
– –
-113,758
Closed -$1.54M
RUSHB icon
1990
Rush Enterprises Class B
RUSHB
$6.44B
– –
-38
Closed -$1.61K
RUSHA icon
1991
Rush Enterprises Class A
RUSHA
$5.6B
– –
-69,605
Closed -$3.07M
RVMD icon
1992
CALL
Revolution Medicines
RVMD
$43.9B
– –
-17,500
Closed -$1.7M
RVLV icon
1993
Revolve Group
RVLV
$1.51B
– –
-145,909
Closed -$3.3M
RXST icon
1994
RxSight
RXST
$194M
– –
-106,638
Closed -$657K
RYN icon
1995
Rayonier
RYN
$5.62B
– –
-64,087
Closed -$1.32M
RZLT icon
1996
Rezolute
RZLT
$376M
– –
-88,226
Closed -$269K
S icon
1997
CALL
SentinelOne
S
$7.79B
– –
-7,000
Closed -$90.2K
SABS icon
1998
SAB Biotherapeutics
SABS
$299M
– –
-768,627
Closed -$2.94M
SANA icon
1999
Sana Biotechnology
SANA
$880M
– –
-61,659
Closed -$178K
SBH icon
2000
Sally Beauty Holdings
SBH
$1.61B
– –
-42,846
Closed -$593K

Similar funds

ExodusPoint Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, ExodusPoint Capital Management held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

ExodusPoint Capital Management's Q2 2026 filing shows 735 new, 384 increased, 378 reduced and 720 closed positions. Its largest new stake was SpaceX: 1,938,935 shares worth $331M. The largest sale was Tesla, an estimated $1.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • ExodusPoint Capital Management's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • ExodusPoint Capital Management added most to Amazon in Q2 2026, an estimated $614M increase.
  • ExodusPoint Capital Management's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • ExodusPoint Capital Management fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • ExodusPoint Capital Management's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • ExodusPoint Capital Management opened 735 new positions and closed 720 in Q2 2026.
  • ExodusPoint Capital Management's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.